NovoThelium Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $75K
Latest Deal Amount
  • Investors
  • 6

NovoThelium General Information

Description

Developer of a decellularization process designed to rebuild tissues in human breast. The company's decellularization process utilizes breast tissue from human donors and removes DNA and donor cells, ensuring certain proteins and structure that lets the nipple be repopulated with the patient's own cells, enabling breast cancer survivors to develop a more natural nipple and areola.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • San Antonio Technology Center
  • 3463 Magic Drive, Suite T15
  • San Antonio, TX 78229
  • United States
+1 (210) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NovoThelium Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 21-Feb-2018 $75K 00.000 Completed Generating Revenue
6. Angel (individual) 17-Jul-2017 000 00.000 Completed Generating Revenue
5. Grant 05-May-2017 0000 00000 Completed Generating Revenue
4. Grant 04-May-2017 000.00 00000 Completed Generating Revenue
3. Accelerator/Incubator 00000 Completed Startup
2. Grant 19-Oct-2016 $10K $139K Completed Startup
1. Angel (individual) $139K $139K Completed Startup
To view NovoThelium’s complete valuation and funding history, request access »

NovoThelium Executive Team (3)

Name Title Board Seat Contact Info
Lauren Cornell Co-Founder & Chief Executive Officer
Bianca Cerqueira Ph.D Co-Founder & Chief Operating Officer
Shatha Dallo Ph.D Chief Scientific Officer
To view NovoThelium’s complete executive team members history, request access »

NovoThelium Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NovoThelium Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MassChallenge Accelerator/Incubator 000 0000 000000 0
Texas Venture Labs Accelerator/Incubator 000 0000 000000 0
Launch SA Other 000 0000 000000 0
Rice Business Plan Competition University 000 0000 000000 0
Houston J. and Florence A. Doswell Foundation Other 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »